FindTrial
Sign In

Boost lymphocyte activation following IMRT in patients with non-small-cell lung cancer: a retrospective study based on medical records

Boost lymphocyte activation following IMRT in patients with non-small-cell lung cancer: a retrospective study based on medical records

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027314
Enrollment
Unknown
Registered
2019-11-08
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

1:IMRT

Sponsors

Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: In our study, data were obtained regarding 54 incident lung cancer cases in the medical record system from 2017 to 2019 with primary lung cancer.

Exclusion criteria

Exclusion criteria: Patients were excluded if there was incomplete therapy information; or if their source documents were from autopsy or death certificate only.

Design outcomes

Primary

MeasureTime frame
OS;—

Countries

China

Contacts

Public ContactChu Qian

Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

574532586@qq.com+86 13212760751

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026